3SBio Inc. — Board/Management Information 2020

Apr 27, 2020

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [110 x 133] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 1530)

VOLUNTARY ANNOUNCEMENT

APPOINTMENT OF CHIEF FINANCIAL OFFICER

The board (the “ Board ”) of directors (the “ Directors ”) of 3SBio Inc. (the “ Company ”, together with its subsidiaries, the “ Group ”) is pleased to announce that with effect from 15 April 2020, Mr. Wang Fei (“ Mr. Wang ”) has been appointed as the chief financial officer of the Company. Mr. Wang will be in charge of finance and accounting, managing and supervising financial reporting, and carrying out investment and finance activities, as well as handling investor relations matters of the Group.

The biographical details of Mr. Wang are as follows:

Mr. Wang is a certified public accountant in the PRC. He has over 20 years of experience in auditing, accounting and finance management. With his abundant wealth of experience in finance management, investment and financing of foreign enterprises and private enterprises, he has both international outlook and the local experience in performing the onshore work. He served as an executive director and a chief financial officer of a Hong Kong listed company. Before joining the Company, Mr. Wang worked in a pharmaceutical company, AstraZeneca, as the chief financial officer of its China operation from January 2011 to October 2015 and as the director of finance of its respiration, immunology and inflammation department from January 2020 to April 2020.

In 1999, Mr. Wang graduated from Xinjiang University of Finance and Economics and obtained a bachelor’s degree in management. He obtained from Shanghai Jiao Tong University and Euromed Marseille Ecole de Management (now known as KEDGE) a master’s degree majoring in business administration in 2012.

1

The Board would like to take this opportunity to welcome Mr. Wang to the Group.

By order of the Board 3SBio Inc. Dr. LOU Jing Chairman

Shenyang, the PRC 27 April 2020

As at the date of this announcement, the Directors of the Company are Dr. LOU Jing and Ms. SU Dongmei as executive Directors; Mr. HUANG Bin and Mr. TANG Ke as non-executive Directors; and Mr. PU Tianruo, Mr. David Ross PARKINSON and Dr. WONG Lap Yan as independent non-executive Directors.

2